AbstractBackground and Aims. Skeletal muscle (SM) fat infiltration, or intermuscular adipose tissue (IMAT), reflects muscle quality and is associated with

Despite the availability of technologies and guideline recommendations, invasive coronary function testing (IFT) remains underperformed in patients with ischemia with no obstructive coronary artery disease (INOCA), but the current state of IFT in Canadian cardiac catheterisation laboratories (CCLs) has remained unknown. Therefore, we conducted a survey among Canadian CCL directors (n = 46). While most CCL directors thought that IFT should be performed in INOCA patients experiencing persistent symptoms or adverse clinical outcomes, only 19.6% (n = 9) and 30.4% (n = 14) of responding centres performed invasive assessment of the microvasculature and vasomotor function, respectively.